The Center for Drug Discovery seeks out and advances promising drug projects from the Washington University community, deploying key activities:
- Identification & Prioritization of Promising Projects
- Education & Project Strategy
- Implementation & Project Management
- Facilitation of External Partnering
The task of identifying projects is conducted with established University partners, including the Institute of Clinical & Translation Sciences (ICTS), the Skandalaris Center for Interdisciplinary Innovation & Entrepreneurship and the Siteman Cancer Center.
The Center works closely with the Center for Research Innovation in Biotechnology (CRIB), which evaluates academic and commercial participation in drug discovery.
Images generously provided by the Centers for Disease Control and Wikimedia Commons